 |
PDBsum entry 1rfu
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Conformational changes in the reaction of pyridoxal kinase.
|
 |
|
Authors
|
 |
M.H.Li,
F.Kwok,
W.R.Chang,
S.Q.Liu,
S.C.Lo,
J.P.Zhang,
T.Jiang,
D.C.Liang.
|
 |
|
Ref.
|
 |
J Biol Chem, 2004,
279,
17459-17465.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
To understand the processes involved in the catalytic mechanism of pyridoxal
kinase (PLK),1 we determined the crystal structures of PLK.AMP-PCP-pyridoxamine,
PLK.ADP.PLP, and PLK.ADP complexes. Comparisons of these structures have
revealed that PLK exhibits different conformations during its catalytic process.
After the binding of AMP-PCP (an analogue that replaced ATP) and pyridoxamine to
PLK, this enzyme retains a conformation similar to that of the PLK.ATP complex.
The distance between the reacting groups of the two substrates is 5.8 A apart,
indicating that the position of ATP is not favorable to spontaneous transfer of
its phosphate group. However, the structure of PLK.ADP.PLP complex exhibited
significant changes in both the conformation of the enzyme and the location of
the ligands at the active site. Therefore, it appears that after binding of both
substrates, the enzyme-substrate complex requires changes in the protein
structure to enable the transfer of the phosphate group from ATP to vitamin
B(6). Furthermore, a conformation of the enzyme-substrate complex before the
transition state of the enzymatic reaction was also hypothesized.
|
 |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Pyridoxal binding site. The molecule in the center
is the pyridoxamine bound in the PLK·AMP-PCP-pyridoxamine
complex. The surrounding residues are shown in green, and the
hydrogen bonds between the pyridoxamine and the residues are
shown as purple dashes. The corresponding residues in the
PLK·ATP complex are in blue. A comparison of these
structures reveals local conformational adjustments of the
pyridoxal binding site when the substrates binds.
|
 |
Figure 5.
FIG. 5. The ADP molecule bound in the PLK·ADP
complex and the residues interacting with it. The hydrogen bonds
between them are shown as blue dashes. The molecule shown as a
thin black line is the ADP in the PLK·ADP·PLP
complex. A significant conformational change happens between the
two ADP molecules.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
17459-17465)
copyright 2004.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Crystal structure of brain pyridoxal kinase, A novel member of the ribokinase superfamily.
|
 |
|
Authors
|
 |
M.H.Li,
F.Kwok,
W.R.Chang,
C.K.Lau,
J.P.Zhang,
S.C.Lo,
T.Jiang,
D.C.Liang.
|
 |
|
Ref.
|
 |
J Biol Chem, 2002,
277,
46385-46390.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Substrate-binding sites of pyridoxal kinase. a,
stereoview of the interactions between ATP and residues of
enzyme in the complex. The bound ATP molecule is shown as a
ball-and-stick model; Zn2+ and K+ are shown as spheres. b, the
pyridoxal-binding site is shown as a transparent electrostatic
surface. Positive regions are blue, and negative regions are
red; the modeled pyridoxal and related residues are shown as
sticks. The positions of the pyridine ring of pyridoxal are
labeled.
|
 |
Figure 5.
Fig. 5. a and b, omit electron density maps of the ATP
molecules bound in the complex in monomer A (a) and monomer B
(b). c, a superimposed view of the active site of pyridoxal
kinase (red), ribokinase (blue), and adenosine kinase (green).
The superimposition is based on the common catalytic residue Asp
and the helix to which it belongs.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the ASBMB
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Crystallization and preliminary crystallographic studies of pyridoxal kinase from sheep brain.
|
 |
|
Authors
|
 |
M.H.Li,
F.Kwok,
X.M.An,
W.R.Chang,
C.K.Lau,
J.P.Zhang,
S.Q.Liu,
Y.C.Leung,
T.Jiang,
D.C.Liang.
|
 |
|
Ref.
|
 |
Acta Crystallogr D Biol Crystallogr, 2002,
58,
1479-1481.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
Figure 1.
Figure 1 (a) Typical trigonal crystal of pyridoxal kinase (0.12
× 0.12 × 0.5 mm); (b) typical orthorhombic crystal of pyridoxal
kinase (0.15 × 0.15 × 0.4 mm).
|
 |
|
 |
 |
|
The above figure is
reproduced from the cited reference
with permission from the IUCr
|
 |
|
|
|
|
 |